Naritaka Tanaka

<i>MiR‐150</i> is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the <scp>EMT</scp> inducer <i><scp>ZEB</scp>1</i>

Takehiko Yokobori, Shigemasa Suzuki, Naritaka Tanaka et al. · Cancer Science · 2012 · 128 citations · Full text

Medicine, Cancer Biology, Oncology +16

CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma

Shigemasa Suzuki, Takehiko Yokobori, Naritaka Tanaka et al. · Oncology Reports · 2012 · 97 citations · Full text

Medicine, Cell Biology, Oncology +17

CD24 Expression Is a Novel Prognostic Factor in Esophageal Squamous Cell Carcinoma

Akihiko Sano, Hiroyuki Kato, Shinji Sakurai et al. · Annals of Surgical Oncology · 2008 · 85 citations

Medicine, Oncology, Pathology +12

The clinical application of ¹⁸F‐fluorodeoxyglucose positron emission tomography to predict survival in patients with operable esophageal cancer

Hiroyuki Kato, Masanobu Nakajima, Makoto Sohda et al. · Cancer · 2009 · 84 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Significance of karyopherin-{alpha} 2 (KPNA2) expression in esophageal squamous cell carcinoma.

Makoto Sakai, Makoto Sohda, Tatsuya Miyazaki et al. · PubMed · 2010 · 75 citations

Medicine, Oncology, Pathology +17